Elite Wealth Management Inc. bought a new position in shares of UnitedHealth Group Inc (NYSE:UNH) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 815 shares of the healthcare conglomerate’s stock, valued at approximately $200,000.

Other large investors also recently bought and sold shares of the company. Welch Group LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth $106,000. Blue Chip Partners Inc. purchased a new stake in shares of UnitedHealth Group during the second quarter worth $107,000. Bamco Inc. NY purchased a new stake in shares of UnitedHealth Group during the first quarter worth $117,000. Northwest Wealth Management LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth $117,000. Finally, Bruderman Asset Management LLC purchased a new stake in shares of UnitedHealth Group during the first quarter worth $134,000. Hedge funds and other institutional investors own 85.39% of the company’s stock.

Several equities research analysts have issued reports on the company. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, June 19th. Cantor Fitzgerald restated a “buy” rating and set a $300.00 target price on shares of UnitedHealth Group in a research report on Thursday, July 5th. BMO Capital Markets increased their target price on UnitedHealth Group from $285.00 to $300.00 and gave the stock a “positive” rating in a research report on Thursday, June 21st. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 11th. Finally, SunTrust Banks began coverage on UnitedHealth Group in a research report on Monday, June 11th. They set a “buy” rating and a $300.00 target price on the stock. Two research analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $272.43.

UnitedHealth Group stock opened at $265.31 on Friday. The firm has a market capitalization of $252.81 billion, a PE ratio of 26.35, a PEG ratio of 1.56 and a beta of 0.71. UnitedHealth Group Inc has a fifty-two week low of $186.00 and a fifty-two week high of $271.16. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.63.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share for the quarter, topping the consensus estimate of $3.04 by $0.10. The firm had revenue of $56.09 billion for the quarter, compared to analysts’ expectations of $56.10 billion. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. The business’s quarterly revenue was up 12.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.46 earnings per share. sell-side analysts anticipate that UnitedHealth Group Inc will post 12.72 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 18th. Investors of record on Friday, September 7th will be paid a $0.90 dividend. The ex-dividend date is Thursday, September 6th. This represents a $3.60 dividend on an annualized basis and a yield of 1.36%. UnitedHealth Group’s dividend payout ratio is presently 35.75%.

UnitedHealth Group declared that its board has approved a share buyback plan on Wednesday, June 6th that permits the company to repurchase 100,000,000 outstanding shares. This repurchase authorization permits the healthcare conglomerate to reacquire shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.

In related news, CEO Steven H. Nelson sold 26,033 shares of the stock in a transaction on Friday, September 7th. The stock was sold at an average price of $270.65, for a total value of $7,045,831.45. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP D Ellen Wilson sold 15,393 shares of the stock in a transaction on Friday, August 24th. The shares were sold at an average price of $264.29, for a total value of $4,068,215.97. Following the completion of the transaction, the executive vice president now directly owns 66,402 shares in the company, valued at approximately $17,549,384.58. The disclosure for this sale can be found here. In the last three months, insiders sold 86,603 shares of company stock worth $22,837,660. 0.87% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: What is the NASDAQ?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.